399
10
Acknowledgments
400
A preprint of this manuscript has been published online at medRxiv.
401
11
Data Availability Statement
The data that support the findings of this study are openly available in SRA at 402 https://www.ncbi.nlm.nih.gov/bioproject/PRJNA922968, reference number PRJNA922968. 403
404
405
406
407
408
409
410
411
412
413
414
415
References
416
1. Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, et al. Disease- 417 associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary 418 disease. Nat Commun. 2020;11(1):5886. 419 2. Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition 420 reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 421 2021;70(4):698-706. 422 3. Yazar A, Atis S, Konca K, Pata C, Akbay E, Calikoglu M, et al. Respiratory symptoms and 423 pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 424 2001;96(5):1511-6. 425 4. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial 426 communities in asthmatic airways. PLoS One. 2010;5(1):e8578. 427 5. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated differences 428 in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346-52 e1-3. 429
15
Powered by FlippingBook